GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Andros Pharmaceuticals Co Ltd (ROCO:6917) » Definitions » ROE % Adjusted to Book Value

Andros Pharmaceuticals Co (ROCO:6917) ROE % Adjusted to Book Value : -11.32% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Andros Pharmaceuticals Co ROE % Adjusted to Book Value?

Andros Pharmaceuticals Co's ROE % for the quarter that ended in Dec. 2024 was -22.07%. Andros Pharmaceuticals Co's PB Ratio for the quarter that ended in Dec. 2024 was 1.95. Andros Pharmaceuticals Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -11.32%.

Andros Pharmaceuticals Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Andros Pharmaceuticals Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Andros Pharmaceuticals Co ROE % Adjusted to Book Value Chart

Andros Pharmaceuticals Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - - - -7.66 -9.28

Andros Pharmaceuticals Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only - -3.50 -10.17 -6.98 -11.32

Competitive Comparison of Andros Pharmaceuticals Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Andros Pharmaceuticals Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Andros Pharmaceuticals Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Andros Pharmaceuticals Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Andros Pharmaceuticals Co's ROE % Adjusted to Book Value falls into.


;
;

Andros Pharmaceuticals Co ROE % Adjusted to Book Value Calculation

Andros Pharmaceuticals Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-18.09% / 1.95
=-9.28%

Andros Pharmaceuticals Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-22.07% / 1.95
=-11.32%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Andros Pharmaceuticals Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Andros Pharmaceuticals Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Andros Pharmaceuticals Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Andros Pharmaceuticals Co Ltd (ROCO:6917) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
ROCO:6827 ROCO:6662 ROCO:6999 ROCO:6549 ROCO:3205 ROCO:6814 ROCO:7607 ROCO:4170 ROCO:6610 ROCO:6876 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 22, Sec. 2, Shengyi Road, 6th Floor, Building D, Biotech Building, Hsinchu Biomedical Science Park, Hsinchu County, Zhubei City, TWN, 30261
Website
http://www.androspharma.com
Andros Pharmaceuticals Co Ltd is a biopharmaceutical company engaged in developing novel drug delivery platform technologies. The firm focuses on the development of topical new dosage forms and non-viral gene delivery systems, with the current pipeline indicated for pain management, DNA repair, and gene therapy. Its product line comprises New Dosage Forms (Topical), Super Generics (Topical), High-End Cosmetic Ingredients (Topical), and Gene Delivery Systems (Injectable).

Andros Pharmaceuticals Co Headlines

No Headlines